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TECHNICAL NOTE
The Influence of Homologous Blood Transfusion on Immunity and
Clinical Outcome in Aortic Surgery
S. L. Haynes∗, J. C. L. Wong, F. Torella, K. Dalrymple, L. Pilsworth and C. N. McCollum
Academic Surgery Unit, South Manchester University Hospital, West Didsbury, Manchester M20 2LR
Objectives: to evaluate the influence of homologous blood transfusion on immune responses and post-operative morbidity
in aortic surgery.
Design: analysis of the effects of homologous blood transfusion in 128 patients in a prospective randomised trial evaluating
homologous and autologous blood transfusion in aortic surgery.
Materials and methods: blood sampled before and at five times after surgery was assayed for C-reactive protein (CRP),
neutrophil elastase, TNF- and IL-6. Transfusions, morbidity and mortality were recorded; factors associated with poor
outcome were identified by logistic regression.
Results: homologous transfusion during surgery was required in 32 patients and precipitated an increase in neutrophil
elastase (p=0.008) and TNF- (p=0.015) but not IL-6 and CRP. Elastase peaked early in transfused patients at 41.27
(13.92–52.11) ng/ml by 2 h compared to a peak of 21.51 (10.64–31.13) ng/ml by 24 h in those who were not transfused.
TNF- peaked at 1.2 (0–4.33) pg/ml by wound closure in transfused patients and at −0.1 (−2.05–2.52) pg/ml by
2 h without transfusion. Intra-operative homologous transfusion was associated with increased mortality (p=0.01) and
prolonged intensive care stay (p=0.03). Mortality increased with age (p=0.003) and was inversely related to the CRP
peak (p=0.007). Prolonged surgery predicted post-operative complications (p=0.025).
Conclusion: homologous transfusion increased the inflammatory response to aortic surgery and was associated with
mortality.
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tion.2,5,6 Immuno-suppression due to homologous
Introduction blood may influence postoperative infection rates,
prognosis in cancer and transplant rejection.7–12 The
Elective surgery accounts for over 40% of all stored precise mechanism of these immune effects has yet to
blood transfusions and an even greater proportion of be characterised but may be mediated by both cellular
cross-match requests.1 Blood transfusion is life saving and humoral components.13
in severe haemorrhage, following trauma or as a com- Autologous blood transfusion may avoid the im-
plication of surgery and its benefits in these indications muno-suppression associated with homologous trans-
are undisputed. However, homologous blood trans- fusion. A number of studies reported marked
fusion was introduced before randomised clinical trials reductions in hospital infection rates, antibiotic usage
were widely adopted and its risks are only now being and even length of hospital stay in patients offered
quantified. Homologous transfusion may induce a autologous transfusion.14–16 However, these studies
number of changes within the immune system, causing were either not randomised, were retrospective or
immuno-suppression and contributing to infectious the numbers of patients involved were inadequate to
complications.2–4 Homologous blood has also been as- influence transfusion policy. In a meta-analysis of
sociated with a variety of transfusion reactions, graft- seven clinical trials on 1060 patients, the risk of post-
versus host disease, allo-immunisation, the trans- operative infection was 2.37 times greater for patients
mission of infectious agents, and immunomodula- receiving homologous blood.12
We investigated the effect of homologous blood
∗ Please address all correspondence to: S. Haynes, Academic Surgery transfusion on inflammatory response and clinical out-Unit, South Manchester University Hospital, Nell Lane, West
Didsbury, Manchester M20 2LR, U.K. come in patients recruited into a randomised clinical
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Table 1. Inclusion and exclusion criteria.
Inclusion Exclusion
Elective infra-renal aortic reconstruction Myocardial infarction in the previous 6 months
Age >30 and <85 years Severe angina (American Heart Society)
Hb >110 g/L Myocardial ischaemia on resting ECG
Platelet count >150 000/L Aortic stenosis
Written informed consent Cardiac ejection fraction <40%
Pre-operative creatinine >200 mmol/L
Aspartate amino-transferase >100 iu/L
Patient refusal of homologous blood
Blood disorders excluding either transfusion technique
Severe pulmonary disease (PaO2 <9 kpa on air; FEV1 <50% predicted)
trial comparing two different blood transfusion strat- Transfusion triggers
egies: autologous versus homologous transfusion
when necessary. The main clinical findings of this trial Homologous blood was administered when the
haemoglobin concentration fell below 80 g/L, unlesshave been reported elsewhere.17 We now report the
results in relation to intraoperative homologous blood salvaged red cells were available. Intraoperatively,
transfusion could also be administered when abnormaltransfusion requirement.
vital signs or ischaemic electrocardiographic changes
persisted after correction of hypovolaemia or in case
of severe haemorrhage.
Materials and Methods
Patients
Autologous transfusion
Following ethical approval and fully informed consent,
128 patients were randomised to either autologous Patients randomised to autologous transfusion under-
went acute normovolaemic haemodilution after in-(acute normovolaemic haemodilution and intra-
operative cell salvage, n=65) or homologous (n=63) duction of anaesthesia and immediately before
surgery. The amount of blood removed was basedtransfusion before elective aortic surgery from June
1997 to July 1999. Table 1 describes the inclusion on the preoperative haemoglobin concentration and
estimated blood volume calculated from publishedand exclusion criteria. There were eight participating
hospitals but randomisation was central, by computer nomograms, aiming for a post-haemodilution haemo-
globin of 105–110 g/L.18,19 Cell salvage was by cent-in the Vascular Studies Unit at South Manchester
University Hospital. Allocation was stratified using rifugal devices (Cell saver 5, Haemonetics, U.K. or
Brat 2, Cobe Laboratories, U.K.). All autologous bloodminimisation for (i) hospital, (ii) aortic disease (an-
eurysm or occlusive), (iii) anti-platelet or anti-co- was re-infused within 6 h of collection.
agulant drugs and (iv) estimated blood volume.
Inflammatory mediators
Anaesthetic technique
Peripheral venous blood was sampled into standard
serum and EDTA blood tubes at six time points: (i)Standard general anaesthetic techniques were used
with intravenous induction, endotracheal intubation preoperatively, and postoperatively at (ii) wound clos-
ure, (iii) 2 h, (iv) day one, (v) day two and (vi) dayand intermittent positive pressure ventilation. Main-
tenance of anaesthesia was by either an intravenous seven. This was immediately centrifuged at 1300 g
for 10 min and plasma/serum samples transferred toor a volatile agent with intraoperative fluids limited
to crystalloids where possible. Colloids were avoided −80 °C storage for subsequent analysis. C-reactive
protein (CRP) was analysed by a standard tur-due to their possible effect on the acute phase response.
Epidural anaesthesia with local anaesthetic drugs was bidometric procedure (Dako, Nycomed, Ely, U.K.).
Plasma samples were used to assess neutrophil elastasedelayed to the postoperative period to avoid ex-
panding the intravascular volume, causing further using an “in house” enzyme-linked immunosorbent
assay, according to the method of Brower and Harpel.20haemodilution.
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Table 2. Patients details.
Intraoperative homologous transfusion
No (n=96) Yes (n=32) p
Median age (IQR) 70 (66–76) years 70 (64–75) years n.s.
Sex (male/female) 80/16 24/8 n.s.
Disease (aneurysm/occlusive) 67/29 27/5 n.s.
Co-morbidities
Cardiac 34 (35%) 12 (37.5%) n.s.
Respiratory 21 (22%) 9 (28%) n.s.
Hypertension 36 (37%) 14 (44%) n.s.
Diabetes 2 0 n.s.
Smoking habit
Yes 25 (26%) 10 (31%) n.s.
No 11 (11%) 4 (12.5%) n.s.
Ex 60 (63%) 18 (66.5%) n.s.
Median aneurysm size (IQR) 6 (5.5–7) cm 6.4 (5.6–7) cm n.s.
Randomisation (autologous/homologous) 58/38 (60%) 7/25 (22%) <0.001
IL-6 and TNF-were measured in serum samples using Transfusion
commercially available paired antibodies (Biosource,
Lifescreen Ltd, Harefield, U.K.). Assays were op- Thirty-two patients required intraoperative trans-
fusion of a median (IQR) of 2 (2–4) homologous units.timised for serum samples to ensure reproducibility
and were sensitive to cytokine concentrations lower One-hundred-and-fourteen of the 119 transfusions
were buffy coat poor red cell units and the remainingthan 5 pg/ml.
five were whole blood units. Transfused patients had
a significantly higher median (IQR) blood loss of 1742
(1102–2825) ml compared to 800 (580–1169) ml
Statistical analysis (p<0.001) as estimated by blood lost to suction and
swab weight. They also received more intravenous
As all continuous variables were skewed, the Mann– fluids during surgery at a median (IQR) of 4450
Whitney U-test was used. The chi-squared test, with (3750–5075) ml compared to 3500 (3000–4500) ml in
the Yates correction where appropriate, was used for patients who were not transfused (p<0.001). Ran-
proportions. To avoid multiple comparisons at dif- domisation to “autologous” reduced the need for ho-
ferent time points mediator concentration changes mologous blood during surgery from 25/63 (40%) to
were summarised calculating the area under the curve 7/65 (11%) (p<0.001).
(AUCs) for each subject. Correlations were calculated
using the Spearman rank correlation coefficient. Back-
ward stepwise multiple logistic regression was used
to identify predictors of mortality, morbidity and post-
Clinical outcomeoperative infection. Co-variates in this analysis were
peaks of mediators concentration, number of pre- Mortality and morbidity for the duration of the in-operative co-morbidities (cardiac disease, respiratory patient stay are summarised in Table 3. Intensive caredisease, hypertension and diabetes), age, aortic disease was required more frequently for transfused patients,(aneurysm or occlusive), transfusion strategy (au- with a median intensive care unit stay (IQR) of 1 (1–2)tologous or homologous), blood loss, operating time days compared to 1 (1–1) days in patients who wereand number of homologous units transfused during not transfused (p=0.03).surgery. In this analysis, continuous variables were
categorised around the median value.
Inflammatory mediators
Results
As expected, there was a marked inflammatory re-
sponse to surgery, and this was enhanced by intra-The study population was typical of any cohort of
patients undergoing aortic surgery (Table 2). operative transfusion. The rise in neutrophil elastase
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Table 3. Postoperative complications.
Intraoperative homologous transfusion
No (n=96) Yes (n=32) p
Deaths 13 (13.5%) 10 (31%) 0.046
Cardiac 14 (15%) 6 (19%) n.s.
Respiratory (not infective) 1 (1%) 3 (10%) n.s.
Respiratory infection 20 (21%) 6 (19%) n.s.
Graft thrombosis 9 (10%) 3 (10%) n.s.
Haemorrhage 4 (4%) 7 (22%) 0.006
Renal 8 (8%) 5 (16%) n.s.
Multiorgan failure 2 (2%) 5 (16%) 0.014
Other 8 (8%)∗ 7 (22%)†
∗ Includes two wound haematomas, two groin wound infections, four intestinal complications.
† Includes one wound haematoma, one groin wound infection, two cases of urinary retention, two urinary tract infections, two intestinal
complications, one deep vein thrombosis, one minor stroke.
was more pronounced in patients requiring intra- was 165 (102–194) mg/L in “autologous” and 165
(111–227) mg/L in “homologous” patients.operative transfusion, with an earlier median (IQR)
peak at 2 h of 80 (67–94) ng/ml compared to 58
(44–72) ng/ml. The volume of blood transfused during
surgery correlated with the rise in neutrophil elastase
Predictors of poor outcomeat wound closure (r=0.26, p=0.005) and at 2 h (r=
0.31, p=0.001). Neutrophil elastase remained elevated Multiple logistic regression (Table 4) identified op-for a week after surgery in transfused cases, with erating time >150 min as the only independent pre-a median (IQR) concentration of 65 (41–88) ng/ml dictor of postoperative complications (p=0.025).compared to 46 (40–63) ng/ml in non-transfused Prolonged surgery (>150 min) also had a weak re-patients a week following surgery. TNF- increased lationship with postoperative infections, with an ORto a median (IQR) 5 (3–13) pg/ml at wound closure (95% CI)=1.5 (0.65–3.66) (p=0.06). The volume offollowing transfusion but, despite the insult of aortic intraoperative homologous transfusion in units wassurgery, did not rise substantially without transfusion. independently related to mortality on regression (p=The rise in TNF- at wound closure also correlated 0.03). Other predictors of mortality were age (p=0.003)with the volume of homologous blood transfused (r= and a CRP peak <158 mg/L (p=0.007). The median0.4; p<0.001). Median TNF- concentration fell below (IQR) CRP concentration at 48 h in patients who sub-baseline in most patients after the first postoperative sequently died was 124 (0–185) mg/L compared to 173day, regardless of transfusion. The IL-6 peak tended (136–212) mg/L in survivors (p=0.01). Preoperativeto occur earlier at 55 (24–164) pg/ml at 2 h in those co-morbidities, blood loss, aortic disease, ran-requiring homologous blood during surgery, com- domisation to either transfusion strategy, neutrophilpared to 45 (20–112) pg/ml at 24 h in those not trans- elastase, TNF- and IL-6 did not predict clinical out-fused. IL-6 returned towards normal by day two. CRP come.trends were similar in the two groups, with peaks
at 48 h of 178 (132–228) and 162 (102–200) mg/L in
transfused and non-transfused patients respectively.
Median CRP concentration returned to baseline on Discussion
day seven in both groups.
Randomisation to autologous transfusion had no Elective aortic reconstruction generated a profound
inflammatory response, amplified by intra-operativesignificant influence on the concentration of neutrophil
elastase (p=0.67), TNF- (p=0.34), IL-6 (p=0.21) or transfusion of stored blood. Exposure to homologous
blood increased intensive care stays and, after ad-CRP (p=0.4). TNF- peaked at 2 h at 6 (3–17) pg/ml
in “autologous” and 5 (2–14) pg/ml in “homologous” justment for confounding variables, mortality. No stat-
istically significant influence of transfusion onpatients. The neutrophil elastase peak at day 1 was 66
(53–97) ng/ml in “autologous” and 63 (50–80) ng/ml postoperative infection was detected in these patients
undergoing clean surgery.in “homologous”. IL-6 also reached its highest con-
centration 24 h following surgery at 73 (24–157) pg/ Previous work has shown that TNF- and IL-6 rise
in response to surgical trauma21 and that, in ischaemia-ml in “autologous” and 47 (19–127) pg/ml in the “ho-
mologous” group. CRP peaked later, at 2 days, and reperfusion injury, TNF- may mediate neutrophil
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accumulation and priming, with levels rising after
aortic cross-clamping and falling quickly after clamp
removal.22 Large increases in TNF- have been as-
sociated with severe complications such as multi-organ
failure,23 but this finding was not confirmed by our
data. In general TNF- levels were not greatly in-
creased in our elective surgery patients with many
assays at the lower limit of sensitivity. Greater rises
may have occurred transiently during surgery, re-
covering by the time blood was sampled after surgery.
Elevated postoperative TNF- was associated with
intraoperative homologous transfusion but there was
no significant correlation between TNF- and mor-
bidity.
IL-6 is a marker of tissue injury and systemic IL-6
responses reflect the severity of surgery.24–26 We dem-
onstrated an IL-6 peak within the first 24 h after surgery
and a sharp fall over the next two days, which is
consistent with previous reports.27 IL-6 is thought to
play a role in the induction of CRP synthesis: CRP
peaked 24 h following the IL-6 response, but neither
mediator was significantly influenced by homologous
transfusion.
Increased neutrophil elastase following surgery has
been related to postoperative complications and may
reflect the overall immune response.28 This increase
was greater in our transfused patients but did not
predict poor outcome. Neutrophil elastase and TNF-
 concentrations are known to be increased in stored
blood.28,29 The increases we measured following sur-
gery were related to the volume of homologous blood
given during surgery and may be partly explained by
the direct infusion of mediators.
Recently, homologous transfusion has been as-
sociated with increased postoperative mortality in
colorectal,30 pulmonary31 and biliary32 surgery. This
association has not been reported in aortic surgery.
In our multivariate model, we included measures of
patient fitness (age, co-morbidities) and severity of
surgery (aortic disease, blood loss, operating time) to
verify this association. Although our results confirm a
direct relationship between intraoperative transfusion
and mortality, it remains impossible to distinguish
entirely the effect of transfusion from the effect of the
clinical conditions leading to transfusion. Mortality in
this study was also suprisingly high, with significant
variation among participating centres. This would tend
to reduce our ability to detect effects due to blood
Fig. 1. Rises in inflammatory mediators in 32 transfused (Χ) and
96 non-transfused (Β) patients. Rises in TNF- (a) and neutrophil
elastase (b) were more pronounced after transfusion (p=0.015 and
p=0.008 respectively). There were no significant differences in IL-
6 (c) and CRP (d). Values are medians and interquartile range.
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Table 4. Perioperative predictors of mortality and complications.
Odds ratio 95% CI p
Mortality
Homologous transfusion (units) 1.7 1.1/2.6 0.01
CRP peak <158 mg/L 5.8 1.6/20.6 0.007
Age (10 years increase) 3.9 1.6/9.3 0.003
Complications
Operating time >2.5 h 3.1 1.5/6.5 0.025
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